miR‐5586‐5p also suppresses the expression of glycolytic genes, lactate dehydrogenase A (LDHA), hexokinase 2 (HK2), phosphoglycerate kinase 1 (PGK1), and solute carrier family 2 member 1 (SLC2A1), thereby suppressing glycolysis and cancer progression [50]. Here, SLC2A1 is linked to cancer.